695 related articles for article (PubMed ID: 33573350)
1. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
Wang L; Eom K; Kwon T
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
[TBL] [Abstract][Full Text] [Related]
2. α-synuclein-assisted oligomerization of β-amyloid (1-42).
Chau E; Kim JR
Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
Gu L; Guo Z
J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
[TBL] [Abstract][Full Text] [Related]
4. Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40.
Kim W; Hecht MH
J Biol Chem; 2005 Oct; 280(41):35069-76. PubMed ID: 16079141
[TBL] [Abstract][Full Text] [Related]
5. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
6. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.
Jan A; Gokce O; Luthi-Carter R; Lashuel HA
J Biol Chem; 2008 Oct; 283(42):28176-89. PubMed ID: 18694930
[TBL] [Abstract][Full Text] [Related]
7. Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.
Fu Z; Van Nostrand WE; Smith SO
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513738
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study.
Li X; Yang Z; Chen Y; Zhang S; Wei G; Zhang L
J Phys Chem B; 2023 May; 127(18):4050-4060. PubMed ID: 37126408
[TBL] [Abstract][Full Text] [Related]
10. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
Gu L; Guo Z
Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
[TBL] [Abstract][Full Text] [Related]
12. Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42.
Chen YR; Glabe CG
J Biol Chem; 2006 Aug; 281(34):24414-22. PubMed ID: 16809342
[TBL] [Abstract][Full Text] [Related]
13. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
[TBL] [Abstract][Full Text] [Related]
14. Solution NMR studies of Aβ monomer dynamics.
Wang C
Protein Pept Lett; 2011 Apr; 18(4):354-61. PubMed ID: 21222639
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms.
Iljina M; Garcia GA; Dear AJ; Flint J; Narayan P; Michaels TC; Dobson CM; Frenkel D; Knowles TP; Klenerman D
Sci Rep; 2016 Jun; 6():28658. PubMed ID: 27346247
[TBL] [Abstract][Full Text] [Related]
16. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
[TBL] [Abstract][Full Text] [Related]
17. Molecular Insights into the Inhibition and Disaggregation Effects of EGCG on Aβ40 and Aβ42 Cofibrillation.
Li X; Zhang Y; Wang Y; Zhang S; Zhang L
J Phys Chem B; 2024 Feb; 128(8):1843-1853. PubMed ID: 38359305
[TBL] [Abstract][Full Text] [Related]
18. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
Coskuner O; Wise-Scira O; Perry G; Kitahara T
ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
[TBL] [Abstract][Full Text] [Related]
19. Key Residue for Aggregation of Amyloid-β Peptides.
Itoh SG; Yagi-Utsumi M; Kato K; Okumura H
ACS Chem Neurosci; 2022 Nov; 13(22):3139-3151. PubMed ID: 36302506
[TBL] [Abstract][Full Text] [Related]
20. Aβ42 and Aβ40: similarities and differences.
Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
